These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10384152)

  • 1. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ.
    Ronsin C; Chung-Scott V; Poullion I; Aknouche N; Gaudin C; Triebel F
    J Immunol; 1999 Jul; 163(1):483-90. PubMed ID: 10384152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.
    Probst-Kepper M; Stroobant V; Kridel R; Gaugler B; Landry C; Brasseur F; Cosyns JP; Weynand B; Boon T; Van Den Eynde BJ
    J Exp Med; 2001 May; 193(10):1189-98. PubMed ID: 11369790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
    Gaudin C; Kremer F; Angevin E; Scott V; Triebel F
    J Immunol; 1999 Feb; 162(3):1730-8. PubMed ID: 9973436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.
    Slager EH; Borghi M; van der Minne CE; Aarnoudse CA; Havenga MJ; Schrier PI; Osanto S; Griffioen M
    J Immunol; 2003 Feb; 170(3):1490-7. PubMed ID: 12538712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
    Kawakami Y; Wang X; Shofuda T; Sumimoto H; Tupesis J; Fitzgerald E; Rosenberg S
    J Immunol; 2001 Feb; 166(4):2871-7. PubMed ID: 11160356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.
    Huang J; El-Gamil M; Dudley ME; Li YF; Rosenberg SA; Robbins PF
    J Immunol; 2004 May; 172(10):6057-64. PubMed ID: 15128789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Fitzgerald EB; Kawakami Y; Rosenberg SA
    J Immunol; 1997 Jul; 159(1):303-8. PubMed ID: 9200467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.
    Torikai H; Akatsuka Y; Miyazaki M; Warren EH; Oba T; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
    J Immunol; 2004 Dec; 173(11):7046-54. PubMed ID: 15557202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells.
    Wang HY; Peng G; Guo Z; Shevach EM; Wang RF
    J Immunol; 2005 Mar; 174(5):2661-70. PubMed ID: 15728473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative translational reading frames as a novel source of epitopes for an expanded CD8 T-cell repertoire: use of a retroviral system to assess the translational requirements for CTL recognition and lysis.
    Carlson TL; Green KA; Green WR
    Viral Immunol; 2010 Dec; 23(6):577-83. PubMed ID: 21142443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription.
    Van Den Eynde BJ; Gaugler B; Probst-Kepper M; Michaux L; Devuyst O; Lorge F; Weynants P; Boon T
    J Exp Med; 1999 Dec; 190(12):1793-800. PubMed ID: 10601354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.
    Echchakir H; Dorothée G; Vergnon I; Menez J; Chouaib S; Mami-Chouaib F
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9358-63. PubMed ID: 12093915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
    J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
    Wang RF; Johnston SL; Zeng G; Topalian SL; Schwartzentruber DJ; Rosenberg SA
    J Immunol; 1998 Oct; 161(7):3598-606. PubMed ID: 9759882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.
    Benlalam H; Linard B; Guilloux Y; Moreau-Aubry A; Derré L; Diez E; Dreno B; Jotereau F; Labarrière N
    J Immunol; 2003 Dec; 171(11):6283-9. PubMed ID: 14634146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
    J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
    Schendel DJ; Gansbacher B; Oberneder R; Kriegmair M; Hofstetter A; Riethmüller G; Segurado OG
    J Immunol; 1993 Oct; 151(8):4209-20. PubMed ID: 8409397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.